Filter by: patients
Home > Community Treatment Reports and Side Effects > Tamiflu Treatment Report
What is Tamiflu?

Tamiflu® is a brand name for oseltamivir, an antiviral agent used to treat uncomplicated acute illness due to influenza. Off label it is used for the treatment and chemoprophylaxis of swine influenza A (H1N1) virus.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Prevent infection 1 1 Efficacy_cant_tell
Flu virus (influenza) 1 0

See all 2 patients currently taking Tamiflu

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 0

Commonly reported side effects, conditions, and hospitalizations associated with Tamiflu

Insomnia 1

Reported Dosages

  1,050 mg yearly 30 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Tamiflu (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 1   Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Tamiflu

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Tamiflu

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Tamiflu

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Tamiflu

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Tamiflu

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Tamiflu

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.